Target (CBDY) Shares Outstanding (Diluted Average) (2018 - 2023)

Target (CBDY) reported Shares Outstanding (Diluted Average) of $456.4 million for Q1 2023, down 26.03% year-over-year from $617.0 million in Q1 2022, and little changed quarter-over-quarter from $454.6 million in Q4 2022.

Target (CBDY) Shares Outstanding (Diluted Average) (2018 - 2023) Analysis & Trends

Target (CBDY) has 5 years of Shares Outstanding (Diluted Average) data on file, last reported at $456.4 million in Q1 2023.

  • Shares Outstanding (Diluted Average) for Q1 2023 came in at $456.4 million, down 26.03% year-over-year; the trailing twelve-month figure through Mar 2023 was $456.4 million (down 26.03% YoY), and the FY2022 annual result was $454.6 million, down 3.76% from the prior year.
  • Shares Outstanding (Diluted Average) steadied at $456.4 million in Q1 2023 per CBDY's latest filing, from $454.6 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $617.0 million in Q1 2022 and troughed at $121.2 million in Q1 2019.
  • A 4-year average of $473.8 million and a median of $473.1 million in 2022 frame the typical range for Shares Outstanding (Diluted Average).
  • The sharpest annual moves came in 2019 and 2023: Shares Outstanding (Diluted Average) soared 97.17% in 2019, then declined 26.03% in 2023.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $121.2 million in 2019, then soared by 289.83% to $472.3 million in 2021, then declined by 3.76% to $454.6 million in 2022, then increased by 0.41% to $456.4 million in 2023.
  • Business Quant data shows CBDY's Shares Outstanding (Diluted Average) at $456.4 million in Q1 2023, $454.6 million in Q4 2022, and $473.1 million in Q3 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Target - - 191,787.00 -

Historic Data

Download Data
DateValue
Mar 31, 2023 456.41 Mn
Dec 31, 2022 454.56 Mn
Sep 30, 2022 473.10 Mn
Jun 30, 2022 606.47 Mn
Mar 31, 2022 617.03 Mn
Dec 31, 2021 472.31 Mn
Sep 30, 2021 489.89 Mn
Jun 30, 2021 573.37 Mn
Mar 31, 2019 121.16 Mn
Mar 31, 2018 61.45 Mn